Antiplatelet Therapy Resistance: Definition, Diagnosis, and Clinical Implications

Saurabh Gupta, Peter J. Casterella

    Research output: Chapter in Book/Report/Conference proceedingChapter

    Original languageEnglish (US)
    Title of host publicationPharmacology in the Catheterization Laboratory
    PublisherWiley-Blackwell
    Pages280-286
    Number of pages7
    ISBN (Print)9781405157049
    DOIs
    StatePublished - Oct 30 2009

    Fingerprint

    Therapeutics
    ST Elevation Myocardial Infarction

    Keywords

    • Antiplatelet therapy resistance-definition, diagnosis, and clinical implications
    • Antiplatelet therapy with aspirin and acute myocardial infarction (AMI)
    • Aspirin benefit after percutaneous coronary intervention (PCI)
    • Aspirin resistance-incidence and clinical implications
    • Clopidogrel benefits in coronary artery disease clinical scenarios
    • Clopidogrel resistance potential mechanisms
    • Platelet resistance
    • Platelet resistance management
    • RESISTOR (Research Evaluation to Study Individuals who Show Thromboxane or P2Y12 Receptor Resistance) trial
    • ST-elevation myocardial infarction (STEMI)

    ASJC Scopus subject areas

    • Medicine(all)

    Cite this

    Gupta, S., & Casterella, P. J. (2009). Antiplatelet Therapy Resistance: Definition, Diagnosis, and Clinical Implications. In Pharmacology in the Catheterization Laboratory (pp. 280-286). Wiley-Blackwell. https://doi.org/10.1002/9781444306347.ch37

    Antiplatelet Therapy Resistance : Definition, Diagnosis, and Clinical Implications. / Gupta, Saurabh; Casterella, Peter J.

    Pharmacology in the Catheterization Laboratory. Wiley-Blackwell, 2009. p. 280-286.

    Research output: Chapter in Book/Report/Conference proceedingChapter

    Gupta, S & Casterella, PJ 2009, Antiplatelet Therapy Resistance: Definition, Diagnosis, and Clinical Implications. in Pharmacology in the Catheterization Laboratory. Wiley-Blackwell, pp. 280-286. https://doi.org/10.1002/9781444306347.ch37
    Gupta S, Casterella PJ. Antiplatelet Therapy Resistance: Definition, Diagnosis, and Clinical Implications. In Pharmacology in the Catheterization Laboratory. Wiley-Blackwell. 2009. p. 280-286 https://doi.org/10.1002/9781444306347.ch37
    Gupta, Saurabh ; Casterella, Peter J. / Antiplatelet Therapy Resistance : Definition, Diagnosis, and Clinical Implications. Pharmacology in the Catheterization Laboratory. Wiley-Blackwell, 2009. pp. 280-286
    @inbook{f6a6d30ec96444e49cb7590167f6aa21,
    title = "Antiplatelet Therapy Resistance: Definition, Diagnosis, and Clinical Implications",
    keywords = "Antiplatelet therapy resistance-definition, diagnosis, and clinical implications, Antiplatelet therapy with aspirin and acute myocardial infarction (AMI), Aspirin benefit after percutaneous coronary intervention (PCI), Aspirin resistance-incidence and clinical implications, Clopidogrel benefits in coronary artery disease clinical scenarios, Clopidogrel resistance potential mechanisms, Platelet resistance, Platelet resistance management, RESISTOR (Research Evaluation to Study Individuals who Show Thromboxane or P2Y12 Receptor Resistance) trial, ST-elevation myocardial infarction (STEMI)",
    author = "Saurabh Gupta and Casterella, {Peter J.}",
    year = "2009",
    month = "10",
    day = "30",
    doi = "10.1002/9781444306347.ch37",
    language = "English (US)",
    isbn = "9781405157049",
    pages = "280--286",
    booktitle = "Pharmacology in the Catheterization Laboratory",
    publisher = "Wiley-Blackwell",

    }

    TY - CHAP

    T1 - Antiplatelet Therapy Resistance

    T2 - Definition, Diagnosis, and Clinical Implications

    AU - Gupta, Saurabh

    AU - Casterella, Peter J.

    PY - 2009/10/30

    Y1 - 2009/10/30

    KW - Antiplatelet therapy resistance-definition, diagnosis, and clinical implications

    KW - Antiplatelet therapy with aspirin and acute myocardial infarction (AMI)

    KW - Aspirin benefit after percutaneous coronary intervention (PCI)

    KW - Aspirin resistance-incidence and clinical implications

    KW - Clopidogrel benefits in coronary artery disease clinical scenarios

    KW - Clopidogrel resistance potential mechanisms

    KW - Platelet resistance

    KW - Platelet resistance management

    KW - RESISTOR (Research Evaluation to Study Individuals who Show Thromboxane or P2Y12 Receptor Resistance) trial

    KW - ST-elevation myocardial infarction (STEMI)

    UR - http://www.scopus.com/inward/record.url?scp=84889275212&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84889275212&partnerID=8YFLogxK

    U2 - 10.1002/9781444306347.ch37

    DO - 10.1002/9781444306347.ch37

    M3 - Chapter

    AN - SCOPUS:84889275212

    SN - 9781405157049

    SP - 280

    EP - 286

    BT - Pharmacology in the Catheterization Laboratory

    PB - Wiley-Blackwell

    ER -